After a recent safety review, the FDA called for restricted use of fluoroquinolones, such as Levaquin and Avelox, in certain patients. These new recommendations come after an expert advisory panel met to review evidence on the safety of using fluoroquinolones to help treat common infections.

Dr. Lindsey R. Baden, an infectious disease physician at Brigham and Women’s Hospital in Boston and a member of the FDA panel, told Consumer Reports fluoroquinolones “should typically be reserved for second-line or even third-line treatment after other antibiotics have failed.” According to Baden, “curbing unnecessary prescribing of fluoroquinolones will save thousands of Americans from needless suffering.”

Multiple Risks Reported

Specifically, the FDA has advised against prescribing Levaquin or Avelox to treat three common illnesses — bronchitis, sinus infections, and urinary tract infections. Use of fluoroquinolones can cause disabling and possibly permanent side effects that affect the muscles, tendons, nerves, joints, and more.

If you or a loved one has taken Levaquin or Avelox and suffered an aortic aneurysm or an aortic dissection, it’s important to be aware of the potential side effects and your rights. If you have immediate medical concerns, consult with your primary physician.

The Law Offices of Foster & Houston will continue to share important news involving fluoroquinolones to help you stay informed. You can learn more about Levaquin and Avelox by visiting our website.

Source: Consumer Report